A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease
NCT01268072 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 61
Last updated 2013-02-20
Summary
The primary objective of this study is to identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPD
Conditions
Sponsors & Collaborators
-
MedImmune LLC
lead INDUSTRY
Principal Investigators
-
Joseph Parker, MD · MedImmune LLC
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2012-11-30
- Completion
- 2013-01-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT00281242 ·Status: COMPLETED
-
Biomarker of Acute Exacerbation of COPD
NCT04963244 ·Status: COMPLETED
-
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622 ·Status: WITHDRAWN
-
Chronic Obstructive Pulmonary Disease (COPD) Biomarker Identification Study
NCT01780298 ·Status: COMPLETED
-
Respiratory Microbiome in COPD and Associated Inmune Response.
NCT03321708 ·Status: UNKNOWN
-
A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population
NCT06724848 ·Status: RECRUITING
-
Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)
NCT00655694 ·Status: WITHDRAWN
-
Asthma Breath Biomarker Assessment
NCT03084016 ·Status: COMPLETED
-
Novel Biomarkers in Chronic Airway Diseases
NCT00849836 ·Status: UNKNOWN
-
Endothelial Dysfunction in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
NCT01460082 ·Status: COMPLETED
-
A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease
NCT02734368 ·Status: TERMINATED
-
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study
NCT02657525 ·Status: UNKNOWN
-
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
NCT00281216 ·Status: COMPLETED
-
T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT00281229 ·Status: COMPLETED
-
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00722267 ·Status: COMPLETED
-
Biomarkers and Genetic Factors Related to Emphysema
NCT00757120 ·Status: COMPLETED
-
Respiratory Microbiome and COPD Exacerbations (RESMECOPD)
NCT03432234 ·Status: UNKNOWN
-
Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints
NCT00292552 ·Status: COMPLETED
-
Evaluation of Biomarkers of COPD Exacerbation
NCT03609541 ·Status: UNKNOWN
-
Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison
NCT02076269 ·Status: COMPLETED ·Phase: PHASE1
-
Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma
NCT02487394 ·Status: TERMINATED
-
Chronic Obstructive Pulmonary Disease Biomarker Study
NCT02050022 ·Status: UNKNOWN
-
An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease
NCT01146392 ·Status: COMPLETED
-
Study of COPD Subgroups and Biomarkers
NCT01969344 ·Status: ACTIVE_NOT_RECRUITING
-
COPD Exacerbation Blood and Urine Biomarkers Study
NCT03823443 ·Status: TERMINATED